[Corticosteroids for treatment of rheumatoid arthritis].
Tanaka
Yoshiya
Y
First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004351:Drug Resistance; D005271:Femur Head Necrosis / Q000139:chemically induced; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009894:Opportunistic Infections / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D005938:Glucocorticoids; D011239:Prednisolone; D008775:Methylprednisolone